, Union Européenne. Parlement européen, RÈGLEMENT 2017/745 du 5 avril 2017 relatif aux dispositifs médicaux

, Panorama de la filière industrielle des dispositifs médicaux en France en 2017, 2018.

. France, Pôle interministériel de prospective et d'anticipation des mutations économiques -PIPAME. Dispositifs médicaux : diagnostic et potentialités de développement de la filière française dans la concurrence internationale, 2011.

F. Premier-ministre, Rapport du 8ème Conseil stratégique des industries de santé (CSIS), Juillet, 2018.

, Laboratoire national de métrologie et d'essais. Rapport d'activité, 2018.

F. Présidence-de-la-république, Loi n° 2003-1199 du 18 décembre 2003 de financement de la sécurité sociale pour, 2004.

. France, Ministère de l'action et des comptes publics. Arrêté du 6 mars 2019 fixant pour l'année 2019 les éléments tarifaires mentionnés aux I et

. France, Direction générale de l'offre de soins. INSTRUCTION N° DGOS/R1/2019/55 du 14 mars 2019 relative aux coefficients applicables aux tarifs des établissements de santé mentionnés au d)

. France, Ministère de la santé

. France and . Sénat, Rapport d'information : Industrie du médicament : mettre la fiscalité en perspective, 2007.

. France, Arrêté du 27 avril 2017 relatif au contrat type d'amélioration de la qualité et de l'efficience des soins mentionné à l'article L. 162-30-2 du code de la sécurité sociale

, Haute Autorité de la santé, Service des bonnes pratiques professionnelles

, Niveau de preuve et gradation des recommandations de bonne pratique, 2013.

, KEwj_laSW_pjkAhVkqnEKHXZyDbwQFjAAegQIAxAC&url=https%3A%2F%2Fw ww.has-sante.fr%2Fupload%2Fdocs%2Fapplication%2Fpdf%2F2013

L. Huot, E. Decullier, and K. Maes-beny, Medical device assessment: scientific evidence examined by the French national agency for health -a descriptive study, BMC Public Health, vol.12, p.585, 2012.

J. Shuren and R. M. Califf, Need for a National Evaluation System for Health Technology, JAMA, vol.316, issue.11, pp.1153-1157, 2016.

M. Gilard, F. Debroucker, and C. Dubray, Scientific evaluation and pricing of medical devices and associated procedures in France, Therapie, vol.68, issue.4, pp.193-208, 2013.

I. C. Santos, G. S. Gazelle, and L. A. Rocha, Medical device specificities: opportunities for a dedicated product development methodology, Expert Rev Med Devices, vol.9, issue.3, pp.299-311, 2012.

K. Lampe, P. Schnell-inderst, and . Integrate-hta,

. Eunethta, Int J Technol Assess Health Care, vol.33, pp.605-608, 2017.

P. Schnell-inderst, J. Mayer, and J. Lauterberg, Health technology assessment of medical devices: What is different? An overview of three European projects, Z Evid Fortbild Qual Gesundhwes, vol.109, issue.4-5, pp.309-327, 2015.

H. Banks, A. Torbica, and C. Valzania, Five year trends (2008-2012) in cardiac implantable electrical device utilization in five European nations: a case study in crosscountry comparisons using administrative databases, Europace, vol.20, issue.4, pp.643-653, 2018.

S. Fuchs, B. Olberg, D. Panteli, and R. Busse, Health technology assessment of medical devices in europe: processes, practices, and methods. Int J Technol Assess Health Care, vol.32, pp.246-255, 2016.

A. Hróbjartsson, F. Emanuelsson, A. Thomsen, J. Hilden, and J. Brorson, Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies, Int J Epidemiol, vol.43, issue.4, pp.1272-1283, 2014.

C. P. Impella, V. A. With, C. Ecmo-for, and . Shock,

C. Identifier,

V. Kuznietsova and R. Woodward, Estimating the Learning Curve of a Novel Medical Device: Bipolar Sealer Use in Unilateral Total Knee Arthroplasties, Economic Evaluation, vol.21, pp.283-94, 2018.

S. Iyengar, S. Girish, and V. Subashchandra, Proctors in interventional cardiology: go beyond mentoring and monitoring! Heart Asia, vol.9, p.10953, 2017.

C. Chen, D. Sanket, and A. Bero, Inclusion of Training Patients in US Food and Drug Administration Premarket Approval Cardiovascular Device Studies, Arch Intern Med, vol.171, issue.6, pp.534-539, 2011.

U. S. Govindarajulu, M. Stillo, and D. Goldfarb, Learning curve estimation in medical devices and procedures: hierarchical modeling, vol.36, pp.2764-2785, 2017.

R. Tarricone, G. Callea, and M. Ogorevc, Prevolnik Rupel V. Improving the Methods for the Economic Evaluation of Medical Devices. Health Econ, vol.26, pp.70-92, 2017.

R. Tarricone, A. Torbica, M. Drummond, and . Group, Key Recommendations from the MedtecHTA Project. Health Econ, vol.26, pp.145-152, 2017.

C. Rothery, K. Claxton, S. Palmer, D. Epstein, R. Tarricone et al.,

, Characterising Uncertainty in the Assessment of Medical Devices and Determining Future Research Needs. Health Econ, vol.26, pp.109-123, 2017.

J. Ollivier, C. Carrié, D. 'houdain, and N. , Are Standard Dosing Regimens of

, Ceftriaxone Adapted for Critically Ill Patients with Augmented Creatinine Clearance? Antimicrob Agents Chemother, vol.63, 2019.

, Chapitre VIII : La fixation du prix des médicaments : des résultats significatifs, des enjeux toujours majeurs d'efficience et de soutenabilité, un cadre d'action à fortement rééquilibrer, Cours des comptes. Rapport Sécurité sociale 2017

, KEwjpmb3miZnkAhXZTxUIHTO8DJsQFjABegQIBRAC&url=https%3A%2F%2Fw ww.ccomptes.fr%2Fsites%2Fdefault%2Ffiles%2F2017-09%2F20170920-rapportsecurite-sociale-2017-fixation-prixmedicaments

J. F. Obadia, D. Messika-zeitoun, and G. Leurent, Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation, N Engl J Med, vol.379, issue.24, pp.2297-2306, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02003312

, Avis relatif à la tarification de MITRACLIP et MITRACLIP NT visés à l'article L. 165-1 du code de la sécurité sociale

. France, Direction générale de l'offre de soins

. Jnks6ghvo9ztcispgvei,

D. Katritsis, W. Zareba, and A. J. Camm, Nonsustained ventricular tachycardia, J Am Coll Cardiol, vol.60, issue.20, pp.1993-2004, 2012.

R. Deo and C. M. Albert, Epidemiology and Genetics of Sudden Cardiac Death, Circulation, vol.125, issue.4, pp.620-637, 2012.

. France and . Cépidc,

. France, Scan santé

S. Sirichand, A. M. Killu, and D. Padmanabhan, Incidence of Idiopathic Ventricular Arrhythmias, Circ Arrhythm Electrophysiol, vol.10, issue.2, 2017.

S. Chugh, K. Reinier, and C. Teodorescu, Epidemiology of Sudden Cardiac Death: Clinical and Research Implications, Prog Cardiovasc Dis, vol.51, issue.3, pp.213-228, 2008.

J. R. Gimeno, M. Tomé-esteban, and C. Lofiego, Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy, Eur Heart J, vol.30, issue.21, pp.2599-605, 2009.

P. Coumel, The management of clinical arrhythmias. An overview on invasive versus non-invasive electrophysiology, Eur Heart J, vol.8, pp.92-101, 1987.

G. Alfred and . Mayer, Rhythmical pulsation in scyphomedusae

, Carnegie Institution of Washington Publication, p.47, 1906.

A. Enriquez, D. S. Frankel, and A. Baranchuk, Pathophysiology of ventricular tachyarrhythmias : From automaticity to reentry, Herzschrittmacherther Elektrophysiol, vol.28, issue.2, pp.149-156, 2017.

G. R. Mines, On dynamic equilibrium in the heart, J Physiol, vol.46, pp.349-82, 1913.

A. Enriquez, D. S. Frankel, and A. Baranchuk, Pathophysiology of ventricular tachyarrhythmias : From automaticity to reentry, Herzschrittmacherther Elektrophysiol, vol.28, issue.2, pp.149-156, 2017.

B. Belhassen, I. Shapira, A. Pelleg, I. Copperman, N. Kauli et al., Idiopathic recurrent sustained ventricular tachycardia responsive to verapamil: an ECGelectrophysiologic entity, Am Heart J, vol.198, issue.4Pt1, pp.1034-1041, 1983.

A. Ajijola, R. Tung, and K. Shivkumar, Ventricular tachycardia in ischemic heart disease substrates, Indian Heart J, pp.66-90, 2014.

P. Kong, P. Christia, and N. Frangogiannis, The Pathogenesis of Cardiac Fibrosis, Cell Mol Life Sci, vol.71, issue.4, pp.549-574, 2014.

J. M. De-bakker, F. J. Van-capelle, and M. J. Janse, Macroreentry in the infarcted human heart: the mechanism of ventricular tachycardias with a "focal" activation pattern, J Am Coll Cardiol, vol.18, issue.4, pp.1005-1019, 1991.

R. Martin, P. Maury, and C. Bisceglia,

, Ventricular Tachycardia Circuits Using Ultra-High-Density Mapping, Circ Arrhythm Electrophysiol, vol.11, issue.10, p.6569, 2018.

B. J. Maron and M. S. Maron, Hypertrophic cardiomyopathy. Lancet, vol.381, pp.242-55, 2013.

D. Corrado, M. S. Link, and H. Calkins, Arrhythmogenic Right Ventricular Cardiomyopathy, N Engl J Med, vol.376, issue.1, pp.61-72, 2017.

S. M. Al-khatib, W. G. Stevenson, and M. J. Ackerman, AHA/ACC/HRS cardiac death: Executive summary: A Report of the American College of, 2017.

. Cardiology/american, Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, Heart Rhythm, vol.15, issue.10, pp.190-252, 2018.

A. St, O. Ziv, and . Ventricular-arrhythmias, Med Clin North Am, 2019.

S. J. Connolly, P. Dorian, and R. S. Roberts, Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial, JAMA, vol.295, issue.2, pp.165-71, 2006.

J. C. Claro, R. Candia, and G. Rada, Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death. Cochrane Database Syst Rev, 2015.

Y. Chen, J. Mao, and C. E. Hop, Physiologically based pharmacokinetic modeling to predict drug-drug interactions involving inhibitory metabolite: a case study of amiodarone, Drug Metab Dispos, vol.43, issue.2, pp.182-191, 2015.

R. Latini, G. Tognoni, and R. E. Kates, Clinical pharmacokinetics of amiodarone, Clin Pharmacokinet, vol.9, issue.2, pp.136-56, 1984.

A. J. Moss and M. Madit-i, J Cardiovasc Electrophysiol, vol.14, issue.9, 2003.

H. U. Klein and S. Reek, The MUSTT study: evaluating testing and treatment, J Interv Card Electrophysiol, vol.4, issue.1, pp.45-50, 2000.

A. Moss, W. Zareba, and W. J. Hall, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, vol.346, issue.12, pp.877-83, 2002.

M. H. Raitt, R. C. Klein, and D. G. Wyse, Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial, Am J Cardiol, 2003.

, Apr, vol.1, issue.7, pp.812-818

S. Connolly, M. Gent, and R. S. Roberts, Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone, Circulation, vol.101, issue.11, pp.1297-302, 2000.

K. H. Kuck, R. Cappato, J. Siebels, and R. Rüppel, Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH), Circulation, vol.102, issue.7, pp.748-54, 2000.

K. Nademanee, G. Veerakul, and M. Mower, Defibrillator Versus beta-Blockers for Unexplained Death in Thailand (DEBUT): a randomized clinical trial, Circulation, vol.107, issue.17, pp.2221-2227, 2003.

J. L. Colquitt, D. Mendes, and A. J. Clegg, Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation, Health Technol Assess, vol.18, issue.56, pp.1-560, 2014.

H. Barakpour, Z. Emkanjoo, and A. Alizadeh, Inappropriate Shock Delivered By

, Implantable Cardioverter Defibrillator -Cardiac Resynchronization Therapy (ICD-CRT) Due To Myopotential Oversensing, Indian Pacing Electrophysiol J, 2009.

K. J. Volosin, D. V. Exner, and M. S. Wathen, Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling, J Cardiovasc Electrophysiol, vol.22, issue.3, pp.280-289, 2011.

A. J. Moss, C. Schuger, and C. A. Beck, Reduction in inappropriate therapy and mortality through ICD programming, N Engl J Med, vol.367, issue.24, pp.2275-83, 2012.

G. H. Bardy, K. L. Lee, and B. Markd, Sudden cardiac death in heart failure trial (SCD-HeFT) investigators. Amiodarone or/and implantable cardioverter defibrillator for congestive heart failure, N Engl J Med, vol.352, pp.225-262, 2005.

A. Auricchio, E. J. Schloss, and T. Kurita, Low inappropriate shock rates in patients with single-and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results, Heart Rhythm, vol.12, issue.5, pp.926-962, 2015.

V. Reddy, M. Reynolds, and P. Neuzil, Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy, N Engl J Med, vol.357, issue.26, pp.2657-2665, 2007.

W. G. Stevenson, D. J. Wilber, and A. Natale, Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial, Circulation, vol.118, issue.25, pp.2773-82, 2008.

J. L. Sapp, G. A. Wells, and R. Parkash, Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs, N Engl J Med, vol.375, issue.2, pp.111-132, 2016.

S. Yamashita, F. Sacher, and S. Mahida, Image Integration to Guide Catheter Ablation in Scar-Related Ventricular Tachycardia, J Cardiovasc Electrophysiol, vol.27, issue.6, pp.699-708, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01936715

M. Takigawa, J. Duchateau, and F. Sacher, Are wall thickness channels defined by computed tomography predictive of isthmuses of postinfarction ventricular tachycardia? Heart Rhythm, 2019.

M. Wolf, F. Sacher, and H. Cochet, Long-Term Outcome of Substrate Modification in Ablation of Post-Myocardial Infarction Ventricular Tachycardia, Circ Arrhythm Electrophysiol, vol.11, issue.2, p.5635, 2018.

F. Sacher, K. Roberts-thomson, and P. Maury, Epicardial ventricular tachycardia ablation a multicenter safety study, J Am Coll Cardiol, vol.55, issue.21, pp.2366-72, 2010.

J. Acosta, D. Penela, and D. Andreu, Multielectrode vs. point-by-point mapping for ventricular tachycardia substrate ablation: a randomized study, Europace, vol.20, issue.3, pp.512-519, 2018.

F. Sacher, M. Wright, and N. Derval, Endocardial Versus Epicardial Ventricular Radiofrequency Ablation, Circ Arrhythm Electrophysiol, vol.6, issue.1, pp.144-50, 2013.

M. Das, J. J. Loveday, and G. J. Wynn, Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values, Europace, vol.19, issue.5, pp.775-83, 2017.

P. Jaïs, P. Maury, and P. Khairy, Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia, Circulation, vol.125, issue.18, pp.2184-96, 2012.

R. Proietti, V. Essebag, and J. Beardsall, Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome, Europace, vol.17, issue.3, pp.461-468, 2015.

P. Jaïs, P. Maury, and P. Khairy, Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia, Circulation, vol.125, issue.18, pp.2184-96, 2012.

M. Vaseghi and K. Shivkumar, Neuraxial modulation for ventricular arrhythmias: a new hope, Heart Rhythm, vol.9, pp.1888-1889, 2012.

. France, Choix méthodologiques pour l'évaluation économique à la HAS. Octobre, 2011.

. France, Agence technique de l'information sur l'hospitalisation. Etude nationale des coûts, vol.93

O. K. Yousuf, R. Zusterzeel, and W. Sanders, Trends and Outcomes of Catheter Ablation for Ventricular Tachycardia in a Community Cohort, JACC Clin Electrophysiol, vol.4, issue.9, pp.1189-1199, 2018.

. France, Agence Régionale de Santé Nouvelle Aquitaine. Schéma régional d'organisation des soins, 2018.

X. Bradley, E. H. Herrin, J. Wang, and Y. , Strategies for reducing the door-toballoon time in acute myocardial infarction, N Engl J Med, vol.355, pp.2308-2320, 2006.

X. Auerbach, A. D. Hilton, J. F. Maselli, J. Pekow, P. S. Rothberg et al.,

. Pk, Shop for quality or volume? Volume, quality, and outcomes of coronary artery bypass surgery, Ann Intern Med, vol.150, pp.696-704, 2009.

J. S. Ross, S. L. Normand, and Y. Wang, Hospital volume and 30-day mortality for three common medical conditions, N Engl J Med, vol.362, issue.12, pp.1110-1118, 2010.

S. Hennessy, Use of health care databases in pharmacoepidemiology, Basic Clin Pharmacol Toxicol, vol.98, issue.3, pp.311-314, 2006.

D. Berdaï, F. Thomas-delecourt, and K. Szwarcensztein, Requests for postregistration studies (PRS), patients follow-up in actual practice: Changes in the role of databases, Therapie, vol.73, pp.13-24, 2018.

H. Tanner, G. Hindricks, and M. Volkmer, Catheter ablation of recurrent scarrelated ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: Results of the prospective multicenter Euro-VT-study, J Cardiovasc Electrophysiol, vol.21, issue.1, pp.47-53, 2010.

S. Niwano, H. Fukaya, and M. Yuge, , vol.of electrophysiologic study

, Circ J, vol.72, issue.2, pp.268-273, 2008.

B. A. Koplan, K. Soejima, K. Baughman, L. M. Epstein, and W. G. Stevenson, Refractory ventricular tachycardia secondary to cardiac sarcoid: Electrophysiologic characteristics, mapping, and ablation, Heart Rhythm, vol.3, issue.8, pp.924-929, 2006.

S. R. Dukkipati, A. Avila, and K. Soejima, Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy, Circ Arrhythm Electrophysiol, vol.4, issue.2, pp.185-194, 2011.

K. H. Kuck, R. R. Tilz, and T. Deneke, Impact of Substrate Modification by

, Catheter Ablation on Implantable Cardioverter-Defibrillator Interventions in Patients With Unstable Ventricular Arrhythmias and Coronary Artery Disease: Results From the Multicenter Randomized Controlled SMS (Substrate Modification Study)

, Arrhythm Electrophysiol, vol.10, issue.3, 2017.

V. Atti, V. Vuddanda, and M. K. Turagam, Prophylactic catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: a systematic review and metaanalysis of randomized controlled trials, J Interv Card Electrophysiol, vol.53, issue.2, pp.207-215, 2018.

G. Cheniti, S. Sridi, and F. Sacher, Post-Myocardial Infarction Scar With Fat Deposition Shows Specific Electrophysiological Properties and Worse Outcome After Ventricular Tachycardia Ablation, J Am Heart Assoc, vol.8, issue.15, p.12482, 2019.

N. Martelli, Evaluation des dispositifs médicaux innovants dans les CHU en vue de leur acquisition état des lieux et élaboration d'un outil d'aide à la décision, 2015.

J. R. Winterfield, A. R. Kent, and E. Karst, Impact of ventricular tachycardia ablation on health care utilization, Heart Rhythm, vol.15, issue.3, pp.355-362, 2018.

A. Porta-sánchez, A. Ha, and X. Wang, Health Care Utilization After

, Ventricular Tachycardia Ablation: A Propensity Score-Matched Cohort Study, Can J Cardiol, vol.35, issue.2, pp.169-177, 2019.